MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about issuance of duplicate certificates

17 Jan 2020 Evaluate

Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), the Registrar and Transfer Agent of Company Karvy Fintech has received requests for issue of duplicate Share Certificates from Shareholder.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..